141 related articles for article (PubMed ID: 38324801)
1. Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway.
Sarı U; Zaman F
Acta Cir Bras; 2024; 39():e390524. PubMed ID: 38324801
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
3. Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3.
Zou B; Wang H; Liu Y; Qi P; Lei T; Sun M; Wang Y
Oncol Rep; 2017 Sep; 38(3):1431-1441. PubMed ID: 28714011
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR.
Laschuk Herlinger A; Lovatto Michaelsen G; Sinigaglia M; Fratini L; Nogueira Debom G; Braganhol E; Brunetto de Farias C; Lunardi Brunetto A; Tesainer Brunetto A; da Cunha Jaeger M; Roesler R
Neuromolecular Med; 2023 Dec; 25(4):573-585. PubMed ID: 37740824
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells.
Wang H; Zhang Z; Wei X; Dai R
J Ovarian Res; 2015 Feb; 8():3. PubMed ID: 25823945
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Hong S; Jiang W; Xu C
J Hematol Oncol; 2014 May; 7():39. PubMed ID: 24886678
[TBL] [Abstract][Full Text] [Related]
7. RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.
He M; Sun HG; Hao JY; Li YL; Yu JK; Yan YY; Zhao L; Li N; Wang Y; Bai XF; Yu ZJ; Zheng ZH; Mi XY; Wang EH; Wei MJ
Oncol Rep; 2013 May; 29(5):1721-9. PubMed ID: 23440494
[TBL] [Abstract][Full Text] [Related]
8. Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway.
Dou L; Zou D; Song F; Jin Y; Li Y; Zhang Y
Chin Med J (Engl); 2021 Dec; 135(4):456-461. PubMed ID: 34935692
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic Acid Analogue-11 Induces Apoptosis of Human Gastric Cancer SGC-7901 Cells via the Epidermal Growth Factor Receptor (EGFR)/Akt/Nuclear Factor kappa B (NF-κB) Pathway.
Li W; Li Q; Wei L; Pan X; Huang D; Gan J; Tang S
Med Sci Monit Basic Res; 2019 Feb; 25():63-75. PubMed ID: 30799435
[TBL] [Abstract][Full Text] [Related]
10. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis.
Huang L; Chen J; Quan J; Xiang D
Bioengineered; 2021 Dec; 12(1):3065-3076. PubMed ID: 34224305
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway.
Lu PH; Kuo TC; Chang KC; Chang CH; Chu CY
Br J Dermatol; 2011 Jan; 164(1):38-46. PubMed ID: 20846305
[TBL] [Abstract][Full Text] [Related]
12. [IL-1β inhibitor sensitizes to olaparib in homologous recombination deficiency proficient ovarian cancer cells].
Xu JF; Cen YX; Tang SS; Ren Y; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2022 Jul; 57(7):519-529. PubMed ID: 35902786
[No Abstract] [Full Text] [Related]
13. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1284 Inhibits Cell Viability and Induces Apoptosis of Ovarian Cancer Cell Line OVCAR3.
Pan C; Wang D; Zhang Y; Yu W
Oncol Res; 2016 Oct; 24(6):429-435. PubMed ID: 28281963
[TBL] [Abstract][Full Text] [Related]
15. Rhizoctonia bataticola lectin induces apoptosis and inhibits metastasis in ovarian cancer cells by interacting with CA 125 antigen differentially expressed on ovarian cells.
Hegde P; B R S; Ballal S; Swamy BM; Inamdar SR
Glycoconj J; 2021 Dec; 38(6):669-688. PubMed ID: 34748163
[TBL] [Abstract][Full Text] [Related]
16. Effects of Wnt/β-Catenin Signal Pathway Regulated by miR-342-5p Targeting CBX2 on Proliferation, Metastasis and Invasion of Ovarian Cancer Cells.
Dou Y; Chen F; Lu Y; Qiu H; Zhang H
Cancer Manag Res; 2020; 12():3783-3794. PubMed ID: 32547214
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells.
Marczak A; Denel-Bobrowska M; Rogalska A; Łukawska M; Oszczapowicz I
Environ Toxicol Pharmacol; 2015 Jan; 39(1):369-83. PubMed ID: 25561091
[TBL] [Abstract][Full Text] [Related]
18. Breviscapine reverses doxorubicin resistance in breast cancer and its related mechanisms.
Fu W; Song J; Li H
Thorac Cancer; 2023 Sep; 14(27):2785-2792. PubMed ID: 37584258
[TBL] [Abstract][Full Text] [Related]
19. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
[TBL] [Abstract][Full Text] [Related]
20. Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells.
Dodier P; Piché A
Gynecol Oncol; 2006 Feb; 100(2):254-63. PubMed ID: 16188300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
